The 'hit-and-run' strategy and viral carcinogenesis

Future Oncol. 2023 Feb;19(5):341-344. doi: 10.2217/fon-2022-1171. Epub 2023 Mar 15.

Angioletta Lasagna¹, Irene Cassaniti², Paolo Sacchi³, Simone Figini¹, Fausto Baldanti^{2

4}, Raffaele Bruno^{3

4}, Paolo Pedrazzoli^{1

5}

¹ Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, 27100, Italy.
² Department of Microbiology & Virology, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, 27100, Italy.
³ Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, 27100, Italy.
⁴ Department of Clinical Surgical Diagnostic & Pediatric Sciences, University of Pavia, Viale Camillo Golgi 19, Pavia, 27100, Italy.
⁵ Department of Internal Medicine & Medical Therapy, University of Pavia, Viale Camillo Golgi 19, Pavia, 27100, Italy.

No abstract available

Keywords: EBV; HBV; cancer; herpes virus; hit-and-run; vaccination; viral infection; virome.

MeSH terms